Continue Annual CT Surveillance
For a never-smoker with a stable 9 mm solid nodule over one year, continue annual CT surveillance for at least one additional year, as stability over 1 year significantly reduces but does not eliminate malignancy risk.
Management Rationale
The 9 mm size places this nodule in a critical decision zone. According to the 2023 ACR Appropriateness Criteria, solid nodules >8 mm typically warrant either PET/CT or continued CT surveillance as equivalent alternatives 1. However, the documented stability over 12 months fundamentally changes the risk assessment.
Why Continued Surveillance is Appropriate
- Stability reduces but doesn't eliminate risk: While 2 years of documented stability is generally considered sufficient to declare a nodule benign 1, your patient has only 1 year of stability documented
- Never-smoker status lowers baseline risk: The absence of smoking history significantly reduces the pre-test probability of malignancy, making a conservative surveillance approach more reasonable
- Size threshold considerations: At 9 mm, this nodule sits just above the 8 mm threshold where aggressive workup (PET/CT or biopsy) becomes standard 1
Specific Surveillance Protocol
Perform the next CT chest without IV contrast in 12 months (making it 2 years total stability assessment). Key technical points:
- Use low-dose technique with thin sections (1.5 mm) 1
- Ensure standardized acquisition protocols for accurate size comparison
- No IV contrast needed 1
Decision Points Going Forward
If stable at 2 years total: No further follow-up required 1
If any growth detected: Proceed immediately to:
- PET/CT for metabolic assessment, OR
- Direct biopsy/resection depending on growth rate and patient factors 1
Important Caveats
Watch for suspicious morphologic features that might warrant earlier intervention even with apparent stability:
- Spiculated or lobulated margins
- Upper lobe location (though yours is right lower lobe)
- Any ground-glass component not previously noted
The never-smoker status is protective but doesn't eliminate risk entirely—adenocarcinomas can occur in never-smokers and may have indolent growth patterns 2.